Skip to content

Viatris VTRS Market capitalization

Market capitalization at other companies

Pfizer logo
PfizerPFE
$159.73B+11.1%
McKesson logo
McKessonMCK
$106B+25.7%
Cencora logo
CencoraCOR
$61.11B+13.4%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$18.07B+11.6%
Roivant Sciences logo
Roivant SciencesROIV
$19.82B+175%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$13.22B+19.9%

Other financials

Income statement

See full
Revenue$3.5B+8.1%
Gross profit$1.2B-0.3%
Operating income-$79.7M+97.2%
Net income$176.4M+106%
EPS (diluted)$0.15+106%

Balance sheet

See full
Cash & equivalents$1.8B+139%
Total debt$14.6B+1.0%
Total equity$14.7B-6.3%
Total assets$36.8B-4.3%

Cash flow

See full
Operating cash flow$388.3M-27.5%
CapEx$39.9M-6.3%
Free cash flow$348.4M-29.3%

Valuation

See full
Enterprise value$31.13B+17.7%
P/S1.3×+0.4×

Profitability

See full
Gross margin34.4%-2.5pp
Operating margin1%
Net margin-2%-1.0pp

Returns & leverage

See full
Return on equity-2%-0.9pp
Debt / equity+0.1×
Current ratio1.6×-0.1×

Where this comes from

Computed from the period-end share price: $15.56B.

The official record: Viatris’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viatris's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viatris's market capitalization?
Viatris (VTRS) reported market capitalization of $15.56B in Q1 2026.
How has Viatris's market capitalization changed year-over-year?
Viatris's market capitalization increased by 49.6% year-over-year, from $10.4B to $15.56B.
What is the long-term trend for Viatris's market capitalization?
Over 4 years (2021 to 2025), Viatris's market capitalization has grown at a -8.5% compound annual growth rate (CAGR), from $66.79B to $46.78B.
What does market capitalization mean?
What the stock market says the company's equity is worth.
How do you interpret market capitalization?
A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
How does market capitalization compare across companies?
Comparable across companies as a size class; the input to every equity-price valuation multiple.